News
Capricor sues partner Nippon Shinyaku in DMD therapy spat
Capricor has filed a lawsuit seeking to split from its commercial partner for Duchenne muscular dystrophy therapy, deramiocel, in the US.
News
Eisai, Biogen face delay to subcutaneous Leqembi
Eisai and Biogen are facing a delay in the FDA review of injectable Leqembi for initial dosing in Alzheimer's, viewed as a key growth driver.
News
J&J seeks to rewrite the script on depression treatment
A survey has found that most patients with depression have little hope of being free of their symptoms, and Johnson & Johnson aims to change that.
Sales & Marketing
The new healthcare playbook: Turning workflow into revenue
Healthcare organisations aren’t struggling because they lack growth strategies, they’re struggling because they can’t operationalise them.
News
Manufacturing hangover drives Daiichi Sankyo into the red
Long-term third-party manufacturing contracts and a slower-than-expected rollout of its cancer ADCs have driven Daiichi Sankyo into a net loss.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
